Publications
- Immunotherapy of small cell lung cancer2020 | Publication without faculty affiliation
- Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Erlotinib in the treatment of advanced non-small cell lung cancer - present experience and results in the Czech Repuiblic2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Biologická léčba karcinomu plic2018 | Second Faculty of Medicine
- Monitoring of the expensive pneumooncological first-line treatment of the advanced non-small cell lung cancer in the TULUNG register in the Czech Republic2017 | Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Current position of afatinib in the therapy of non-small cell lung carcinoma2017 | Publication without faculty affiliation
- Afatinib - drug profile2017 | Publication without faculty affiliation
- Crizotinib in the treatment of generalized non-small-cell lung cancer - a case report2017 | Publication without faculty affiliation
- Osimertinib - a new oral third-generation EGFR TKI2017 | Publication without faculty affiliation
- Imunoterapie v první linii léčby nemalobuněčného karcinomu plic2017 | Publication without faculty affiliation
Loading network view...